
Devika Syamnath
None at Reuters
Articles
-
1 week ago |
today.westlaw.com | Nupur Anand |Alan Barona |Jaiveer Shekhawat |Devika Syamnath
(Reuters) -JPMorgan Chase & Co CEO Jamie Dimon has sold about $31.5 million worth of the bank's shares, according to a regulatory filing. Dimon had also offloaded some shares last year in his first such sale since taking over the top role in 2005....
-
2 weeks ago |
today.westlaw.com | Vijay Kishore |Manas Mishra |Devika Syamnath
(Reuters) -Shares of U.S. health insurers jumped on Tuesday after a bigger-than-expected increase in the government's reimbursement rates for Medicare Advantage plans in 2026 signaled some relief for a sector burdened with steep medical costs....
-
1 month ago |
today.westlaw.com | Tanay Dhumal |Devika Syamnath
(Reuters) - Swiss private equity firm Partners Group will buy an energy asset management platform and certain gas-fired power plants in California from U.S.-based Avenue Capital Group for $2.2 billion, the companies said on Tuesday.
-
1 month ago |
today.westlaw.com | Shilpi Majumdar |Tanay Dhumal |Devika Syamnath
(Reuters) -Chemicals firm DuPont De Nemours said on Monday insider Jon Kemp will take over as CEO of its independent electronics unit following the planned spinoff of the business. It is also looking to appoint an external hire as chief financial...
-
1 month ago |
gurutrade.com | Sneha K |Sriparna Roy |Devika Syamnath
March 13 (Reuters) - Mallinckrodt and Endo , drugmakers with a shared history of facing U.S. opioid litigation, have agreed to merge in a deal valued at nearly $7 billion. Under the terms of the agreement, Endo shareholders will get $80 million in cash and own 49.9% of the combined company on a pro forma basis, the companies said on Thursday. Mallinckrodt shareholders will own 50.1% of the combined company for an implied pro forma enterprise value of $6.7 billion.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →